Abstract Factor V (F5) genetic variants and maternal smoking during pregnancy individually has been associated with increased risk of preterm delivery (PTD). We hypothesize that F5 gene and maternal smoking may synergistically increase the risk of PTD. Three single nucleotide polymorphisms (SNPs) in F5 gene (rs6019, rs2213869 and rs6022) were genotyped in 542 mothers with PTD and 1,141 mothers with term deliveries at the Boston Medical Center. The individual and interactive eVects of F5 SNPs and maternal smoking on PTD and gestational age were examined, respectively. The results suggested that maternal smoking, three F5 SNPs and F5 haplotype were individually associated with PTD and gestational age. More importantly, we found signiWcant interactions between the two F5 SNPs (rs6019 and rs6022) and maternal smoking on PTD and gestational age. Compared with non-smoking mothers carrying rs6019 GG genotype, persistently smoking mothers carrying genotypes GC or CC were associated with signiWcantly increased risk of PTD (OR(95% CI): 2.1(1.2-3.6) for GC; 5.7(2.1-15.0) for CC; p-interaction = 0.02). A signiWcant interaction was also observed for gestational age. Similar pattern of interactions was found between rs6022 and maternal smoking on PTD. In summary, our data indicated that F5 gene variants and maternal smoking may synergistically increase the risk of PTD.
Introduction
Preterm delivery (PTD <37 weeks of gestation) is one of the leading causes of death among infants and is associated with signiWcant postnatal morbidities and developmental disabilities (Goldenberg 2002) . The overall rate of preterm birth was 12.7% in the U.S. in 2004 (Martin et al. 2006) . There is compelling evidence that PTD is a complex disease inXuenced by multiple genetic and environmental factors and gene-environment (G£E) interactions (Crider et al. 2005; Goldenberg et al. 2008; Macones et al. 2004 ). This report focused on the inXuence of factor V (F5) gene and maternal smoking during pregnancy on PTD.
Maternal smoking has been recognized as a common and preventable risk factor for PTD (Cnattingius 2004; Fantuzzi et al. 2007; Pollack et al. 2000; Wang et al. 2002) . The biological mechanisms by which cigarette smoking aVects PTD are not yet fully understood, but may be partially due to its well-established procoagulant eVects (Wannamethee et al. 2005) . Factor V (F5) serves as a critical cofactor for the prothrombinase activity of factor Xa, a central regulator of hemostasis. The mutation in F5 has been found to be associated with resistance to activated protein C (APC) (Bertina et al. 1994; Dahlback and Hildebrand 1994; Dawood et al. 2007) and results in increasing level of procoagulant factor Va (Rosing et al. 1998) . Our group has previously demonstrated that F5 haplotype was associated with PTD in 758 mothers enrolled at Boston Medical Center (BMC) (Hao et al. 2004) . Given smoking and F5 both aVect coagulation status and PTD, we hypothesize that they may have synergistic eVects on the risk of PTD, which has not been examined in published literature.
This study had two purposes. First, we intended to replicate our previous Wndings (Hao et al. 2004 ) of haplotype association of F5 genetic variants (rs6019, rs2213869 and rs6022) with PTD using newly enrolled subjects in the BMC cohort as well as in pooled samples. Second, we sought to test the new hypothesis that there was a signiWcant interaction between maternal smoking during pregnancy and F5 gene variants on the risk of PTD in the pooled samples.
Materials and methods

Study population and data collection
The study sample for this report included the subjects from our previous report (Hao et al. 2004 ) (Wrst sample) and new subjects recruited subsequently (second sample). The pooled samples (combining Wrst and second sample) included 1,683 mothers (542 preterm mothers and 1,141 term controls) enrolled at the BMC during the period of 1998-2004 (Wang et al. 2002) . Case mothers were deWned as those delivering a singleton live birth at less than 37 weeks gestation, and controls were deWned as mothers delivering at greater than or equal to 37 weeks gestation. Birth weight was not included as part of the deWnition of preterm cases or full-term controls. Pregnancies resulting in multiple births and newborns with major birth defects were excluded. Detailed description was published previously (Wang et al. 2002) . BrieXy, we collected comprehensive epidemiologic data, clinical data and maternal venous blood samples in this study. After informed consent was obtained, a maternal questionnaire interview was administered 1 day post normal spontaneous vaginal delivery and 2-3 days post c-section to obtain relevant information including demographics, medical and reproductive history, cigarette smoking, alcohol consumption, illicit drug use, diet and stress. Maternal and infant medical records were reviewed to obtain clinical information including prenatal care, pregnancy complications, and birth outcomes. Overall the participation rate was »90%. The Institutional Review Boards at the Boston University Medical Center, the Massachusetts Department of Public Health, the Children's Memorial Hospital in Chicago, and the Harvard School of Public Health approved the study protocol. All participants gave written informed consent.
DeWnition of phenotypes
Preterm delivery was evaluated using both continuous and binary (<37 gestational weeks vs. ¸37 gestational weeks) outcomes. Gestational age was assessed using an algorithm based on last menstrual period and the result of early ultrasound (<20 weeks gestation). The last menstrual period estimate was used only if conWrmed by ultrasound within 7 days or if no ultrasound estimate was obtained; otherwise, the ultrasound estimate was used. This approach has been used in previous studies (Kramer et al. 1998; Wang et al. 2002) .
Maternal cigarette smoking
The information on maternal smoking was obtained from a standard postpartum questionnaire interview for four time periods: 3 months before the index pregnancy and the Wrst, second, and third trimesters of the index pregnancy. Maternal smoking data were clustered into three groups: (1) Those who did not smoke throughout the index pregnancy (never smokers); (2) those who smoked during pregnancy but quit smoking during any trimester (intermittent smokers); and (3) those who smoked continuously during the index pregnancy (persistent smokers).
Genotyping
F5 SNP genotyping and quality assurance
Three F5 SNPs (rs6019, rs2213869 and rs6022) were genotyped in 1,683 mothers. DNA was extracted from samples of venous whole blood in accordance with standard protocol (Sambrook et al. 1989) . SNP genotyping was performed either by the BeadArray™ technology of Illumina Inc (Hao et al. 2004) or by the TaqMan allelic discrimination method (Hong et al. 2007 ). For quality assurance, each plate included one blank control (no DNA template). A random 5% of the samples were independently repeated using both genotyping platforms. The concordance of these duplicated samples was greater than 99.5% for each SNP.
Ancestry informative markers (AIMs) genotyping
The information of ethnicity is based on self-identiWed ethnicity in a standard questionnaire interview by our trained staV. To estimate individual admixture proportions in African Americans in the BMC cohort, we genotyped a panel of 61 AIMs with averaged (diVerence of allele frequencies between African and European ancestral populations) equal to 0.59 in 735 African American mothers (296 preterm cases and 439 controls). Detailed information regarding polymorphic site, Xanking sequence and other relevant information for all the 61 AIMs can be found in previous publication (Yang et al. 2005 ).
Statistical analyses
We Wrst assessed whether each F5 SNP was under HardyWeinberg equilibrium (HWE) among controls in three ethnic groups (African Americans, Hispanics and Whites) using the exact tests implemented in the SNP-HWE program (Wigginton et al. 2005) . We also calculated pair-wise linkage disequilibrium (LD) (r 2 measures) for three F5 SNPs among controls in three ethnic groups, separately, using the Haploview program (Barrett et al. 2005) .
For replication of the haplotype association, we Wrst reconstructed haplotype for three F5 SNPs (rs6019, rs2213869 and rs6022) in three ethnic groups, separately, using EM algorithm implemented in gap, an R package (Zhao 2007) . Next, the F5 haplotype associations with PTD were performed in the Wrst and second sample as well as the pooled samples, respectively, using Chi-square test. Likewise, similar replication analysis was carried out in African American mothers only (the Wrst, second and the pooled samples, individually).
For testing F5 £ smoking interaction, we applied logistic regression and linear regression to examine the individual and interactive eVects of F5 genetic polymorphisms and maternal smoking on the risk of PTD in the pooled samples, African American mothers only and White/Hispanic mothers only, respectively. The interactions of maternal smoking and F5 SNPs were tested by adding a product term in the model. Since the sample size of intermittent smoking during pregnancy was small, the mothers with intermittent smoking were only included in the analyses for testing individual eVects, not in those for testing interactive eVect. To minimize false positive results due to multiple testing issue, we applied false discovery rate (FDR) to correct for multiple testing (Benjamini and Yekutieli 2001) . Based on FDR, we determined the adjusted signiWcance threshold as 2 £ 10 ¡2 and applied this threshold in the subsequent analyses.
All analyses included the following covariates: maternal age (<20, 20-24, 25-29, and ¸30 years), ethnicity (African Americans, Hispanics and Whites), education (less than high school, high school, and greater than high school), parity (0, 1, and ¸2), marital status (married, other), maternal pre-pregnant body mass index (BMI) (<20, 20-24, 25-29, and ¸30), alcohol use (yes/no), passive smoke exposure (yes/no), drug use (yes/no), infant gender and small for gestational age (SGA) status (Wang et al. 2006) . We performed parsimonious model and a model including wellrecognized risk factors of PTD by the literature and our previous work. We found consistent results regardless of the numbers of covariates included in the models, indicating the robustness of our results. In this study, we reported the results with the adjustment of the above covariates.
We previously identiWed the interaction of two metabolic genes (CYP1A1 and GSTT1) with maternal smoking during pregnancy on PTD in this study population (Tsai et al. 2008) . To assess if these genetic variants and their interactions with smoking could aVect our analysis, we included the genetic variants of CYP1A1 and GSTT1 and their interaction with maternal smoking in the regression models for testing F5 £ smoking interaction.
Due to data availability, we were able to perform a subset analysis to assess potential population stratiWcation confounding in African American mothers. We Wrst estimated individual admixture proportions using 61 AIMs data by applying a Bayesian approach implemented in the Structure program (Falush et al. 2003; Pritchard et al. 2000) . We then repeated regression analyses in 735 African American mothers with and without adjusting for ancestral proportions.
Data analyses were performed using statistical packages R 2.6.2 and SAS (Version 9.0, SAS Institute, Inc., Cary, NC, USA).
Results
Demographic, clinical and genetic characteristics
The pooled samples consist of a total number of 1,683 mothers (542 PTD cases, and 1,141 term controls) in this study. The distributions of maternal pre-pregnant BMI, maternal age, ethnicity, educational status, parity, alcohol use, passive smoking exposure and infant sex were similar in preterm versus term groups (Table 1 ). The proportions of unmarried mothers and maternal smoking and drug use during pregnancy were higher in the preterm cases than those in the term group. The prevalence of SGA was higher in the term group than in the preterm group. All three F5 genetic polymorphisms were under HWE in each of the three ethnic groups. The distributions of genotype frequencies for these three SNPs were diVerent between preterm and term groups (Table 1) . Additionally, the pair-wise LD measures (r 2 measures) between rs6019, rs2213869 and rs6022 among three ethnic groups were as follows: rs6019 versus rs2213869, rs6019 versus rs6022 and rs2213869 versus rs6022 in African American: 0.74, 0.37 and 0.50; in White: 1.0, 0.24 and 0.24; and in Hispanic: 0.92, 0.26 and 0.29.
Replication of the F5 haplotype association
We previously reported that F5 haplotypes (rs6019, rs2213869 and rs6022) were associated with PTD in the 1st sample (Hao et al. 2004) . In this study, we analyzed the F5 haplotype association with PTD in the Wrst and second samples, separately, and then repeated the analysis in the pooled samples. Of note, 60% of the study sample was African Americans; therefore, similar analysis was carried out in the African American mothers. As shown in Supplemental Table 1 , we observed that the trend of diVerent haplotypes was comparable among the pooled samples, Wrst and second sample, and in African Americans, respectively. A similar trend of haplotype association in the second sample with marginal signiWcance (P = 0.11); and importantly we replicated the association in the second sample among the African American mothers (P = 0.02). In addition, the previously reported signiWcant haplotype association with PTD was conWrmed in the pooled samples (P < 10 ¡3 ).
Individual associations of maternal smoking and F5 variants with PTD Table 2 showed the individual associations of maternal smoking during pregnancy and F5 polymorphisms with PTD and gestational age among all mothers, after adjusting for important covariates. Compared with never smoking mothers, persistent smoking was signiWcantly associated with the increased risks of PTD (OR (95% CI) = 1.6 (1.1-2.3)), and with lower gestational age ( (SE) and P = ¡0.86 (0.29) and 3.1 £ 10 ¡3 ). Intermittent smoking also increased the risk of PTD (OR (95% CI) = 1.1 (0.7-1.7)) and decreased the gestational age ( (SE) and P = ¡0.23 (0.35) and 0.51), but not statistically signiWcant.
All three SNPs of F5 gene were individually associated with the increased risk of PTD. For rs6019, in comparison with the GG genotype, subjects carrying one or two C alleles had greater ORs for PTD (OR = 1.3, 95% CI: 1.0-1.6; and OR = 1.8, 95% CI: 1.2-2.6, respectively). For rs2213869, in comparison with the GG genotype, subjects carrying one or two A alleles had greater ORs for PTD (OR = 1.1, 95% CI: 0.9-1.4; and OR = 1.7, 95% CI: 1.3-2.3), respectively. For rs6022, in comparison with the CC genotype, subjects carrying one or two A alleles had greater ORs for PTD (OR = 1.1, 95% CI: 0.9-1.5; and OR = 1.6, 95% CI: 1.1-2.1, respectively). Similarly, compared to mothers with homozygous genotype (GG for rs6019, GG for rs2213869 and CC for rs6022), those with high-risk homozygous genotype (CC for rs6019, AA for rs2213869 and AA for rs6022) had lower gestational age ( (SE) and P = ¡1.06 (0.31) and 7 £ 10 ¡4 for rs6019; ¡0.68 (0.25) and 6.3 £ 10 ¡3 for rs2213869; and ¡0.65 (0.25) and 8.6 £ 10 ¡3 for rs6022). Similar associations were found in stratiWed analysis for AA mothers and White/Hispanic mothers, respectively (Supplement Table 2 ).
Interactions of maternal smoking and F5 variants on PTD As mentioned above, the pair-wise LD of rs6019 and rs2213869 was high across three ethnic groups. Therefore, our analysis on F5 and smoking interactions focused on two F5 SNPs on exons (rs6019 and rs6022), and we removed rs2213869 due to its high LD with rs6019. As shown in Table 3 , we found signiWcantly interactive eVects of F5 SNPs (rs6019 and rs6022) and maternal smoking on PTD and gestational age. Using never smoking mothers with low-risk allele as the reference group, persistent smoking mothers with one or two copies of high-risk allele of F5 SNPs (rs6019 and rs6022) had signiWcantly higher risk of PTD and lower gestational age, respectively (Table 3 ; Fig. 1 ). Using rs6019 as an example, compared with never smoking mothers with GG genotype, those who smoked during pregnancy and carried genotypes GC or CC were associated with substantially increased risk of PTD (OR for GC: 2.1 (95% CI: 1.2-3.6); OR for GG: 5.7 (95% CI: 2.1-15.0); p-interaction = 0.02). Such an interactive association was also observed for gestational weeks ( (SE) = ¡0.97 (0.36); p-interaction = 0.007). Likewise, the interactive eVects of rs6022 and maternal smoking were also observed for PTD and gestational weeks. Of note, the joint eVects on PTD and gestational age remained statistically signiWcant after correcting for multiple testing (Table 3) . Our data also indicated that the interactive associations appear to be consistent across ethnic groups, as illustrated in Fig. 1 and in Table 4 , respectively.
Since both our previous report and current analysis found that F5 haplotypes were associated with PTD, we further examined the interaction between F5 haplotypes and maternal smoking on PTD. The results indicated a suggestive, but not statistically signiWcant interaction between F5 haplotype and maternal smoking on PTD after accounting for multiple testing. Additionally, the results in African 
¡3
American mothers were very similar with or without the adjustment of ancestral proportions (Supplemental Table 3 ).
Adjustment of other potential PTD-related risk factors
In addition to smoking, several environmental factors have been previously reported to be associated with PTD, including pre-pregnant BMI, alcohol use and illicit drug use. Therefore, we also examined whether these factors could interact with F5 gene or modify the association between F5 gene and maternal smoking on PTD. We found that none of these risk factors was interactive with F5 gene on PTD (data not shown). However, these potential risk factors were also taken as covariates in interaction models. Furthermore, since our group demonstrated a signiWcant interaction between two metabolic genes (CYP1A1 and GSTT1) and maternal smoking on the increasing risk of PTD (Tsai et al. 2008) , we repeated the above analyses with the adjustment of these two metabolic genetic variants and their interaction with maternal smoking during pregnancy.
The joint eVects between F5 variants and maternal smoking on PTD remained statistically signiWcant (Tables 3, 4) . Taken together, our data provided strong evidence that the interaction between F5 gene and maternal smoking on PTD was independent of major environmental confounders, population admixture, and the interaction between CYP1A1, GSTT1 and maternal smoking.
Discussion
Consistent with previous reports, we observed that maternal smoking during pregnancy was associated with a moderately increased risk of PTD (Cnattingius 2004; Fantuzzi et al. 2007; Ness et al. 1999; Pollack et al. 2000; Shah and Bracken 2000; Wang et al. 1997) . We also replicated the previous Wndings (Hao et al. 2004 ) that F5 haplotypes were associated with the increased risk of PTD in the pooled samples and in African American mothers. More importantly, this is the Wrst report that demonstrated a signiWcant interaction between F5 gene variants and maternal persistent smoking which led to a substantially increased risk of PTD.
The underlying biologic mechanism of the observed interaction between maternal smoking and F5 genetic variants remains to be elucidated, but appears to be biologically plausible. The eVect of smoking on procoagulation has been well documented. First, previous Wndings have suggested that tobacco smoke increases blood viscosity and hematocrit or/and plasma viscosity (Wannamethee et al. 2005) , impairs t-PA (tissue plasminogen activator) releasing from the vascular endothelium (Eliasson et al. 1995) and increases the plasma concentrations of t-PA antigen, plasminogen activator inhibitor (PAI) (Wannamethee et al. 2005 ) and prothrombin fragment F1 + 2 (Nagashima et al. 2007 ). Second, it has been reported that smoking during pregnancy reduces the activity of an anticoagulant, activated protein C (APC) (Kafkas et al. 2007) . Third, several studies have suggested that smoking during pregnancy may result in hypoxia of placenta and fetus (Longo 1976 ) and nicotine, a strong vasoconstrictor, may lead to reduce uterine and placental blood Xow (Walsh 1994). On the other hand, factor V (F5) is known as a key enzyme in the coagulation cascade. The abnormality of F5 protein can lead to an increased tendency towards thrombosis. SpeciWcally, several studies have provided strong evidence that the factor V Leiden, a mutant in F5 gene causing a single amino acid substitution of arginine 506 to glutamine, aVects one of the APC cleaving sites, and increases procoagulant factor Va concentration (Bertina et al. 1994; Dahlback and Hildebrand 1994; Rosing et al. 1998) . Taken together, it is likely that smoking mothers with high-risk genotypes of F5 gene may have a higher procoagulant status, especially in the Fig. 1 Using non-smoking mothers with homogenous genotype as a reference group (GG + never for rs6019 and CC + never for rs6022), odds ratios of PTD among other groups were plotted in all mothers, African American (AA) mothers and White/Hispanic mothers, separately. Note: never and persistent indicate never smoking and persistent smoking during pregnancy, respectively third trimester given the procoagulant status increases with gestational age (Kafkas et al. 2007 ).
There were several strengths in the present study. First, this was one of the largest gene-environment studies on PTD. As such, it provided us suYcient power to investigate the individual eVects and interactions of F5 gene-maternal smoking. Second, the detected interactions between F5 gene and maternal smoking appear to be independent of other known environmental confounders, and the known metabolic genes (CYP1A1 and GSTT1)-smoking interactions (Tsai et al. 2008) . Third, the observed associations are robust in the models regardless of numbers of covariates adjusted, or with or without adjustment for population admixture in African Americans. Fourth, the interactive eVects of F5 gene and maternal smoking on PTD appear to be consistent across ethnic groups. Therefore, we believe On the other hand, a number of limitations should be considered. First, information on maternal smoking may be subject to recall bias. However, previous studies have demonstrated fair agreement between self-reported smoking amounts with serum and urinary levels of cotinine, a biochemical marker of cigarette smoke (George et al. 2006; KlebanoV et al. 2001; Peacock et al. 1998) . However, those studies in which reported smoking was validated against cotinine were by and large prospective cohorts. To address this concern, we compared 277 subjects' smoking status between self-report in the postpartum questionnaire and medical record documentation. Of note, the data in medical record documentation was collected prospectively during each trimester and may be subject to less recall bias. There was over 99% agreement between self-reported smoking and medical record documentation. Although the mothers might over or under report their smoking amounts and duration, they were unaware of their genotypes. Thus, recall bias should be independent of maternal genotypes. Recall bias, if any, most likely biased the G £ smoking interactions towards the null. Second, due to sample size constraints, we did not evaluate the interactive eVect in White and Hispanic mothers separately. Future investigation of these two groups is warranted. Third, this report only focused on three F5 SNPs that we reported previously. It will be of interest to examine other candidate F5 genetic variants, especially the factor V Leiden (the minor allele frequency was very low (<1%) in this study sample). Fourth, even though both rs6019 and rs6022 locate in exons of F5 gene, no functional study of these two SNPs has been reported. Since rs6019 leads to a missense amino acid change, we further used PolyPhen to predict the potential functional impact caused by the missense amino acid change on rs6019. The output indicated that the missense amino acid change on rs6019 did not lead to functional change of protein function. It will be of importance to further investigate the underlying biological function of the two SNPs. Fifth, the sample size in White/Hispanic mothers was small, speciWcally, the groups of persistent smoking mothers with rs6019 genotype CC and persistent smoking mothers with rs6022 genotype AA, it will be of interest to examine ethnic-speciWc interactive eVect when larger sample size of White/Hispanic mothers is available. Sixth, we did not genotype AIMs for the entire study sample. However, our analysis on AIMs in African American mothers (the largest ethnic group in our sample) indicated that population admixture was not a major confounder in our analysis. Last, we did not genotype newborns in this analysis. It would be useful to simultaneously investigate the joint eVect of maternal and fetal genotypes on PTD in future studies.
In summary, we have demonstrated coherent evidence of the synergistic interaction between maternal smoking and F5 genetic polymorphisms on PTD. Smoking women carrying high-risk genotypes of F5 gene may be at a substantially higher risk of PTD. Our Wndings have raised the possibility that women at high risk of PTD can be identiWed by simultaneously examining both environmental exposures and genetic polymorphisms. The Wndings in this study may help identify high-risk individuals well before preterm birth occurs, so that eVective and targeted preventive and therapeutic measures can be implemented.
